Early brain vulnerability in Wolfram syndrome

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Hershey, Tamara ^a   Lugar, Heather M ^a   Shimony, Joshua S ^a   Rutlin, Jerrel ^a   Koller, Jonathan M ^a   Perantie, Dana C ^a   Paciorkowski, Alex R ^a   Eisenstein, Sarah A ^a   Permutt, M Alan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANXIETY; ARTICLE; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN RADIOGRAPHY; BRAIN REGION; BRAIN SIZE; BRAIN STEM; CEREBELLUM; CHILD; CLINICAL ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE DEGENERATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC RADIATION; OPTIC TRACT; PRESCHOOL CHILD; SCHOOL CHILD; SYMPTOM; WHITE MATTER; WOLFRAM SYNDROME;

ADOLESCENT; ADULT; BRAIN; BRAIN STEM; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; ORGAN SIZE; WOLFRAM SYNDROME; YOUNG ADULT;

EID: 84863818278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040604     Document Type: Article

References (101)

1. Barrett TG, Bundey SE, Fielder AR, Good PA, (1997) Optic atrophy in Wolfram (DIDMOAD) syndrome. Eye 11: 882-888.
2. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, et al. (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20: 143-148.
3. D'Annunzio G, Minuto N, D'Amato E, De Toni T, Lombardo F, et al. (2008) Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness)- Clinical and genetic study. Diabetes Care 31: 1743-1745.
4. Rigoli L, Lombardo F, Di Bella C, (2011) Wolfram syndrome and WFS1 gene. Clin Genet 79: 103-117.
5. Fonseca SG, Ishigaki S, Oslowski CM, Lu S, Lipson KL, et al. (2010) Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 120: 744-755.
6. Riggs AC, Bernal-Mizrachi E, Ohsugi M, Wasson J, Fatrai S, et al. (2005) Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 48: 2313-2321.
7. Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, et al. (2001) WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Human Molecular Genetics 10: 477-484.
8. Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, et al. (2004) Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 13: 1159-1170.
9. Yamada T, Ishihara H, Tamura A, Takahashi R, Yamaguchi S, et al. (2006) WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum Mol Genet 15: 1600-1609.
10. Akiyama M, Hatanaka M, Ohta Y, Ueda K, Yanai A, et al. (2009) Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia 52: 653-663.
11. Yamamoto H, Hofmann S, Hamasaki DI, Yamamoto H, Kreczmanski P, et al. (2006) Wolfram syndrome 1 (WFS1) protein expression in retinal ganglion cells and optic nerve glia of the cynomolgus monkey. Exp Eye Res 83: 1303-1306.
12. Engin F, Hotamisligil GS, (2010) Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes Obes Metab 12: 108-115.
13. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140.
14. Kim I, Xu W, Reed JC, (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7: 1013-1030.
15. Lin W, Popko B, (2009) Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 12: 379-385.
16. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, et al. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68: 577-589.
17. Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, et al. (2004) Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 75: 1032-1045.
18. Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, et al. (2002) Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39: 91-97.
19. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 11-19.
20. Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, et al. (2010) Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 25: 948-959.
21. Hilson JB, Merchant SN, Adams JC, Joseph JT, (2009) Wolfram syndrome: a clinicopathologic correlation. Acta Neuropathol (Berl) 118: 415-428.
22. Hardy C, Khanim F, Torres R, Scott-Brown M, Seller A, et al. (1999) Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 65: 1279-1290.
23. Pakdemirli E, Karabulut N, Bir LS, Sermez Y, (2005) Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome. Australas Radiol 49: 189-191.
24. Scolding NJ, KellarWood HF, Shaw C, Shneerson JM, Antoun N, (1996) Wolfram syndrome: Hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 39: 352-360.
25. Khardori R, Stephens JW, Page OC, Dow RS, (1983) Diabetes-Mellitus and Optic Atrophy in 2 Siblings- A Report on A New Association and A Review of the Literature. Diabetes Care 6: 67-70.
26. Jackson MJ, Bindoff LA, Wever K, Wilson JN, Ince P, et al. (1994) Biochemical and Molecular Studies of Mitochondrial-Function in Diabetes-Insipidus, Diabetes-Mellitus, Optic Atrophy, and Deafness. Diabetes Care 17: 728-733.
27. Gregorios JB, (1989) Wolframs Syndrome with Schizophrenia and Central Hypoventilation- A Neuropathological Study. Journal of Neuropathology and Experimental Neurology 48: 308.
28. Carson MJ, Slager UT, Steinberg RM, (1977) Simultaneous occurrence of diabetes mellitus, diabetes insipidus, and optic atrophy in a brother and sister. Am J Dis Child 131: 1382-1385.
29. Kehl O, Keller U, (1982) [DIDMOAD syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, deafness) with cerebello-pontine atrophy]. Schweiz Med Wochenschr 112: 348-352.
30. Rando TA, Horton JC, Layzer RB, (1992) Wolfram Syndrome- Evidence of A Diffuse Neurodegenerative Disease by Magnetic-Resonance-Imaging. Neurology 42: 1220-1224.
31. Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C, (1999) MRI of Wolfram syndrome (DIDMOAD). Neuroradiology 41: 729-731.
32. Barrett TG, Bundey SE, Macleod AF, (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346: 1458-1463.
33. Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, et al. (2011) Neurologic features and genotype-phenotype correlation in wolfram syndrome. Ann Neurol 69: 501-508.
34. Wechsler D, (1999) Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychological Corporation.
35. Conners CK, Epstein JN, Angold A, Klaric J, (2003) Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol 31: 555-562.
36. Wechsler D, (1991) Wechsler Intelligence Scale for Children. 3rd Revision ed. Cleveland, OH: The Psychological Corporation.
37. Wechsler D, (1997) Wechsler Adult Intelligence Scale- III. San Antonio, TX: The Psychological Corporation.
38. Delis D, Kaplan E, Kramer J, (2000) California Verbal Learning Test-II. San Antonio, TX: The Psychological Corporation.
39. Fridlund AJ, Delis DC, (1994) California Verbal Learning Test - Children's Version. San Antonio, TX: The Psychological Corporation.
40. Achenbach TM, Rescorla LA, (2001) Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families.
41. Han X, Jovicich J, Salat D, van der KA, Quinn B, et al. (2006) Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 32: 180-194.
42. Jovicich J, Czanner S, Greve D, Haley E, van der KA, et al. (2006) Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 30: 436-443.
43. Mac Donald CL, Johnson AM, Cooper D, Nelson EC, Werner NJ, et al. (2011) Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med 364: 2091-2100.
44. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, et al. (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33: 341-355.
45. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, et al. (2004) A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 23: 724-738.
46. Lee NJ, Park IS, Koh I, Jung TW, Rhyu IJ, (2009) No volume difference of medulla oblongata between young and old Korean people. Brain Res 1276: 77-82.
47. Dale AM, Fischl B, Sereno MI, (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9: 179-194.
48. Fischl B, Dale AM, (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97: 11050-11055.
49. Fischl B, Sereno MI, Dale AM, (1999) Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9: 195-207.
50. Mechelli A, Price CJ, Friston KJ, Ashburner J, (2005) Voxel-based morphometry of the human brain: Methods and applications. Current Medical Imaging Reviews 1: 105-113.
51. Wilke M, Holland SK, Altaye M, Gaser C, (2008) Template-O-Matic: a toolbox for creating customized pediatric templates. Neuroimage 41: 903-913.
52. Salmond CH, Ashburner J, Vargha-Khadem F, Connelly A, Gadian DG, et al. (2002) Distributional assumptions in voxel-based morphometry. Neuroimage 17: 1027-1030.
53. Ashburner J, Friston KJ, (2000) Voxel-based morphometry- The methods. Neuroimage 11: 805-821.
54. Worsley KJ, Liao CH, Aston J, Petre V, Duncan GH, et al. (2002) A general statistical analysis for fMRI data. Neuroimage 15: 1-15.
55. Moorhead TW, Job DE, Spencer MD, Whalley HC, Johnstone EC, et al. (2005) Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia. Neuroimage 28: 544-552.
56. Basser PJ, Mattiello J, LeBihan D, (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66: 259-267.
57. Shimony JS, McKinstry RC, Akbudak E, Aronowitz JA, Snyder AZ, et al. (1999) Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology 212: 770-784.
58. Mukherjee P, Bahn MM, McKinstry RC, Shimony JS, Cull TS, et al. (2000) Differences between gray matter and white matter water diffusion in stroke: diffusion-tensor MR imaging in 12 patients. Radiology 215: 211-220.
59. Beaulieu C, (2002) The basis of anisotropic water diffusion in the nervous system- a technical review. NMR Biomed 15: 435-455.
60. Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E, et al. (2000) Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med 44: 259-268.
61. Bjorntorp P, (2000) White matter changes and metabolic alterations. In: Pantoni L, Inzitari D, Wallin A, editors. Utrecht: Hoonte Bosch & Keuning pp. 325-334 eds. The Matter of White Matter.
62. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, et al. (2003) Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52: 149-156.
63. Sierra C, de La SA, Mercader J, Gomez-Angelats E, Urbano-Marquez A, et al. (2002) Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 20: 519-524.
64. Oishi K, Zilles K, Amunts K, Faria A, Jiang H, et al. (2008) Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage 43: 447-457.
65. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, et al. (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
66. Nichols TE, Holmes AP, (2001) Nonparametric permutation tests for functional neuroimaging experiments: A primer with examples. Hum Brain Mapp 15: 1-25.
67. Morriss-Kay GM, Wilkie AO, (2005) Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 207: 637-653.
68. Giedd JN, (2004) Structural magnetic resonance imaging of the adolescent brain. Ann N Y Acad Sci 1021: 77-85.
69. Sgouros S, Goldin JH, Hockley AD, Wake MJ, Natarajan K, (1999) Intracranial volume change in childhood. J Neurosurg 91: 610-616.
70. Woods BT, Ward KE, Johnson EH, (2005) Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment. Schizophr Res 73: 221-228.
71. Nopoulos PC, Aylward EH, Ross CA, Mills JA, Langbehn DR, et al. (2011) Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 134: 137-142.
72. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, et al. (2010) Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci 30: 4419-4427.
73. Jellinger K, Armstrong D, Zoghbi HY, Percy AK, (1988) Neuropathology of Rett syndrome. Acta Neuropathol 76: 142-158.
74. Kerbrat A, Aubert-Broche B, Fonov V, Narayanan S, Sled JG, et al. (2012) Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. Neurology 78: 194-201.
75. Genis D, Davalos A, Molins A, Ferrer I, (1997) Wolfram syndrome: A neuropathological study. Acta Neuropathol (Berl) 93: 426-429.
76. Shannon P, Becker L, Deck J, (1999) Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol (Berl) 98: 304-308.
77. Limperopoulos C, du Plessis AJ, (2006) Disorders of cerebellar growth and development. Curr Opin Pediatr 18: 621-627.
78. Barkovich AJ, Millen KJ, Dobyns WB, (2009) A developmental and genetic classification for midbrain-hindbrain malformations. Brain 132: 3199-3230.
79. Fiskum G, Starkov A, Polster BM, Chinopoulos C, (2003) Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann N Y Acad Sci 991: 111-119.
80. Meda SA, Pryweller JR, Thornton-Wells TA, (2012) Regional brain differences in cortical thickness, surface area and subcortical volume in individuals with williams syndrome. PLoS One 7: e31913.
81. Macey PM, Moiyadi AS, Kumar R, Woo MA, Harper RM, (2011) Decreased Cortical Thickness in Central Hypoventilation Syndrome. Cereb Cortex.
82. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junque C, et al. (2011) Assessment of cortical degeneration in patients with parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp.
83. Scheel C, Rotarska-Jagiela A, Schilbach L, Lehnhardt FG, Krug B, et al. (2011) Imaging derived cortical thickness reduction in high-functioning autism: key regions and temporal slope. Neuroimage 58: 391-400.
84. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, et al. (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436.
85. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, et al. (2005) Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140.
86. Nair G, Tanahashi Y, Low HP, Billings-Gagliardi S, Schwartz WJ, et al. (2005) Myelination and long diffusion times alter diffusion-tensor-imaging contrast in myelin-deficient shiverer mice. Neuroimage 28: 165-174.
87. Budde MD, Xie M, Cross AH, Song SK, (2009) Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 29: 2805-2813.
88. Budde MD, Kim JH, Liang HF, Russell JH, Cross AH, et al. (2008) Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed 21: 589-597.
89. Loy DN, Kim JH, Xie M, Schmidt RE, Trinkaus K, et al. (2007) Diffusion tensor imaging predicts hyperacute spinal cord injury severity. J Neurotrauma 24: 979-990.
90. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, et al. (2003) Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20: 1714-1722.
91. Sun SW, Liang HF, Schmidt RE, Cross AH, Song SK, (2007) Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging. Neurobiol Dis 28: 30-38.
92. DeBoy CA, Zhang J, Dike S, Shats I, Jones M, et al. (2007) High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 130: 2199-2210.
93. Reuhl KR, (1991) Delayed expression of neurotoxicity: the problem of silent damage. Neurotoxicology 12: 341-346.
94. Brancati F, Dallapiccola B, Valente EM, (2010) Joubert Syndrome and related disorders. Orphanet J Rare Dis 5: 20.
95. Nickl-Jockschat T, Kunert HJ, Herpertz-Dahlmann B, Grozinger M, (2008) Psychiatric symptoms in a patient with Wolfram syndrome caused by a combination of thalamic deficit and endocrinological pathologies. Neurocase 15: 47-52.
96. Raud S, Sutt S, Luuk H, Plaas M, Innos J, et al. (2009) Relation between increased anxiety and reduced expression of alpha1 and alpha2 subunits of GABA(A) receptors in Wfs1-deficient mice. Neurosci Lett 460: 138-142.
97. Schmahmann JD, (2004) Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 16: 367-378.
98. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, et al. (2007) Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 30: 2331-2337.
99. Perantie DC, Koller JM, Weaver PM, Lugar HM, Black KJ, et al. (2011) Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development. Diabetes 60: 3006-3014.
100. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, et al. (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55: 326-333.
101. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, et al. (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49: 2472-2480.